DNA synthesis has always been at the heart of molecular biology, but the way we design and build genetic sequences is undergoing a major transformation. For decades, phosphoramidite chemistry dominated the production of synthetic DNA, enabling researchers to order short oligonucleotides for PCR, cloning, and sequencing. Today, the field is moving into a new era: enzymatic DNA synthesis and automated platforms are emerging as powerful technologies that promise to deliver longer, faster, and more accurate DNA constructs. These innovations are reshaping how labs approach genome engineering, synthetic biology, and biotechnology at scale.
in News
Traditional vs. next-generation synthesis
Conventional phosphoramidite chemistry is reliable but limited. It works well for sequences up to about 200 bases, but longer constructs require labor-intensive assembly, error correction, and costly outsourcing
Next-generation synthesis addresses these challenges:
- Enzymatic DNA synthesis (EDS): Uses DNA polymerases, template-independent enzymes (like TdT), or engineered variants to build DNA sequences directly from nucleotides.
- Automated DNA synthesis platforms: Integrate robotics, microfluidics, and machine learning to streamline oligo design, error correction, assembly, and validation into a single workflow.
Enzymatic DNA synthesis (EDS)
Enzymatic approaches represent one of the most exciting shifts in DNA technology. Instead of relying on chemical coupling steps, EDS employs engineered enzymes to add nucleotides with high accuracy.
Key advantages
Longer continuous sequences: Potential to synthesize kilobase-scale fragments without stitching multiple short oligos.
Reduced error rates: Improved accuracy compared to chemical synthesis, especially when coupled with error-checking enzymes.
Environmentally friendly: Eliminates toxic solvents and reagents associated with chemical synthesis.
Faster iteration cycles: Researchers can design and produce constructs in days instead of weeks.
Automated DNA synthesis platforms
Automation is a parallel revolution. Modern platforms combine robotics with advanced bioinformatics to accelerate the design–build–test–learn cycle.
Features of automated platforms:
- Microfluidics: Miniaturized reactions reduce reagent costs and increase throughput.
- AI-assisted design: Predicts error-prone regions, optimizes codon usage, and guides sequence assembly.
- Integrated error correction: Uses enzymatic proofreading or sequencing feedback to ensure accuracy.
- Scalability: Enables high-throughput production of thousands of constructs for pathway optimization or screening.
Applications in genome engineering and synthetic biology
These next-generation synthesis technologies are not just faster they are enabling new possibilities:
1
Metabolic engineering
Rapid construction of multi-gene pathways for biomanufacturing of fuels, chemicals, and pharmaceuticals.
2
Synthetic genomes
Stepwise synthesis of large DNA fragments allows the creation of minimal genomes and designer chromosomes.
3
Standardization
Different platforms use unique chemistries and workflows, complicating cross-lab reproducibility.
4
Scale-up for clinical use
Regulatory frameworks must catch up with large-scale DNA synthesis to ensure safety and security.